US pharmaceutical giant Pfizer has said it has yet to decide on whether it will sell its infant nutrition business following claims that HJ Heinz, Nestle and Danone have made bids for the unit.

Pfizer told just-food today (10 January) that it is continuing to look at the options for the baby food business after starting to weigh up the alternatives last year.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

“The process of exploring strategic alternatives for Pfizer’s Nutrition business is ongoing,” Pfizer said. “We’re currently pursuing the activities associated with evaluating all options, including sale, spin-off or other transaction. However, no decisions have been made at this point.”

The company said it expected to make a decision later this year with “any transactions” completed between July this year and July 2013.

Earlier today, The New York Post, citing unnamed sources, reported that Heinz, Nestle and Danone had made first-round bids for Pfizer’s infant nutrition business. Pfizer, the report claimed, would soon be arranging meetings with the bidders.

See Also:

Heinz, Danone and Nestle have all been touted as potential buyers of the business since Pfizer said it was considering the “strategic alternatives” for the unit in July.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Pfizer’s nutrition business sells products including infant formulas and growing-up milks in over 60 countries. It operates from five plants in Ireland, China, Singapore, the Philippines and Mexico and, in 2010, it generated sales of around US$1.9bn in 2010.

Shares in Pfizer were up 0.32% at $21.89 at 15:40 ET today. Shares in Heinz were down 0.38% to $53.04 at 15:41.

Nestle’s shares on the Swiss Stock Exchange finished up 0.92% at CHF54.80. Shares in Danone closed down 0.18% at EUR48.89 in Paris.